Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Nasopharyngeal Carcinoma 14Triple Negative Breast Neoplasms 12Carcinoma, Non-Small-Cell Lung 10Esophageal Squamous Cell Carcinoma 9Breast Neoplasms 8Colorectal Neoplasms 7Carcinoma, Renal Cell 7Small Cell Lung Carcinoma 6Neoplasms 6Advanced Solid Tumor 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Head and Neck Neoplasms 5Urinary Bladder Neoplasms 4Recurrence 4Carcinoma, Hepatocellular 4Stomach Neoplasms 3Solid Tumor 3Neoplasm Metastasis 3Liver Neoplasms 3Carcinoma, Transitional Cell 3Turcot syndrome 2Sarcoma 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2NSCLC 2Muscle Invasive Bladder Cancer (MIBC) 2Carcinoma, Squamous Cell 2Biliary Tract Neoplasms 2Advanced Solid Tumors 2

Interventions

toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Small Cell Lung Cancer Limited Stage × toripalimab × 1 year × Clear all
NCT04418648 2026-02-04

Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy

Sun Yat-sen University

Phase 2 Terminated
170 enrolled
Thoracic

Small Cell Lung Cancer Limited Stage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡